Information Provided By: 
Fly News Breaks for October 6, 2015
BRKR
Oct 6, 2015 | 07:33 EDT
After speaking with the directors of four large Nuclear Magnetic Resonance labs, which are either current or prospective Bruker customers, Wells Fargo thinks that the pricing of the company's BioSpin division, which accounts for 34% of its revenue, is rising. The firm recommends buying the stock following its recent decline. It says that the company's NMR customers appear to be satisfied, and it keeps an Outperform rating on the shares.
News For BRKR From the Last 2 Days
There are no results for your query BRKR
